Biotech

Fund raising activity goes 'cold' in India; PE, VC investments may dip up to 60% in 2020 due to COVID-19: EY

In the past few years, fund raising activity has been touching record highs, and grew 28 percent to $48 billion in 2019.

University of California to be granted patent of CRISPR gene-editing tech: Report

CRISPR works as molecular scissors that can trim away unwanted pieces of genetic material.

China's first commercial genetic pet cloning service duplicates a star canine

Sinogene which offers pet cloning carried out the process with the help of a surrogate mother beagle.

The slinky sister of CRISPR that 'skips' over regions in DNA that cause disease

The technique still has one big hurdle to cross before heading towards clinical trials.

Biotech company may have unlocked the secret to reduce nicotine levels in cigarettes and tobacco plants

Investors are betting on a little-known biotech company to supply Big Tobacco with low-nicotine cigarettes.

Biotech company, Biocon reports 52 percent annual growth

Biotech major Biocon Ltd on Thursday reported Rs 147 crore consolidated net profit for second quarter (July-September) of fiscal 2016-17, registering 57 per cent annual growth from Rs 97 crore in same period year ago.

Nasscom’s bleak outlook for IT sector: From lower jobs to Brexit impact

Nasscom's statements assume significance as the three major IT services companies of the country - Wipro, Infosys and TCS - have come out with a not-so-impressive earnings, giving rise to concerns about the jobs creation potential of the sector

From cloud to 3D printing to robotics, here's where design tech space is heading

Cloud-based tools and services are giving small designers and architecture firms the ability to collaborate with global teams and take on large-scale projects.

PM launches first indigenously developed Rotavirus vaccine

Billed as one of the first novel vaccines to be developed completely in the developing world, it is expected to help in significant reduction in infant deaths due to Rotavirus diarrhoea in India and other parts of the world.

The biotech debate: Too important to leave to politicians to decide

Biotechnology is too complex and important to be left to the politicians alone. It is time an independent authority looked into the research, safety, release, and labeling of biotech products.